Is Alleima (OM:ALLEI) Expensive On Airbus Deal And India Expansion News?

Alleima (OM:ALLEI) is in focus after two closely timed updates. The company extended its long partnership with Airbus around titanium seamless tubes and committed to a SEK 220 million tubing capacity investment in India.

These announcements appear to sit alongside a strong recent run in Alleima’s shares, with a 90 day share price return of 42.57% and a year to date share price return of 45.73%, while the 1 year total shareholder return of 79.32% points to strong momentum building rather than fading.

Spot similar momentum in other industrial and materials stocks by scanning our hand picked list of solid balance sheet and fundamentals (426 results) as a comparison point to Alleima's recent moves.

After that kind of surge and fresh contract and capacity news, the real puzzle for Alleima now is timing. Does buying after this run still make sense, or is patience for a softer entry the better call on valuation?

Most Popular Narrative: 32% Overvalued

Alleima's most followed narrative places fair value at SEK92.40, which is below the last close of SEK121.90, so the story hinges on how future growth and margins unfold under a 6.93% discount rate.

The company's continued shift toward high-margin, specialty and customized solutions (notably in Medical, Nuclear, and precision Strip), combined with ongoing automation and operating leverage initiatives, is positioning Alleima for structural net margin expansion and stronger earnings resilience as volumes recover and low value-add exposures diminish.

Read the complete narrative. Read the complete narrative.

Want to see what is baked into that SEK92.40 fair value for Alleima? The narrative leans heavily on faster earnings growth, firmer margins, and a richer future earnings multiple. The interesting part is how those three levers interact across several years of forecasts and a single discount rate.

Result: Fair Value of SEK92.40 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Alleima's story can change quickly if weak demand in core industrial and chemical markets persists, or if raw material and currency swings keep pressuring margins.

Find out about the key risks to this Alleima narrative.

Another View On Alleima’s Valuation

While the popular Alleima narrative points to a fair value of SEK92.40 and a 32% premium at the current price, the Simply Wall St DCF model comes to a different conclusion. On that framework, Alleima at SEK121.90 trades about 12% below an estimated cash flow value of SEK138.98.

For investors comparing these signals, the key question is which set of assumptions feels more realistic for revenue, margins, and discount rate over time, and which one you trust more when expectations clash so clearly.

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Alleima for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 267 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If the mixed messages on Alleima have you on the fence, take a closer look at the full picture, decide quickly where you stand, and then review the 2 key rewards

Looking for more investment ideas beyond Alleima?

If Alleima has sharpened your focus on quality and timing, do not stop here. Use the Simply Wall St screener to explore additional opportunities.

• Target stocks that combine resilience with steadier risk profiles by checking companies in the 300 resilient stocks with low risk scores.
• Hunt for stronger value opportunities by reviewing the 267 high quality undervalued stocks that pair solid fundamentals with current pricing.
• Pinpoint companies that the market may be overlooking by scanning our 611 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com